A drug recently approved to prevent migraine may start working right away, according to a new study. The study looked at the drug atogepant, which is a calcitonin gene-related peptide (CGRP) receptor antagonist taken by mouth.
from Top Health News -- ScienceDaily https://ift.tt/FBxV7DL
the news of the day, for today, top news of today, world news today live, top local news, top news stories of the day, top news today in the world, news today nyc, top news today local,
Subscribe to:
Post Comments (Atom)
Researchers map the brain's self-healing abilities after stroke
A new study sheds light on one of the most severe consequences of stroke: damage to the brain's 'cables'-- the so-called nerve f...
-
from Yahoo News - Latest News & Headlines https://ift.tt/m2VMCS1
-
from Yahoo News - Latest News & Headlines https://ift.tt/jYPuwNf
-
from Yahoo News - Latest News & Headlines https://ift.tt/Ot2Ebrh
No comments:
Post a Comment